Tackling Cardiovascular Risk: New Evidence from Personalized Medicine

Background: The definition of the individual's molecular profile will promote a specific and tailored therapeutic approach for each patient. This method has found application in specific drug decision-making in the oncology field, but not for cardiovascular pathologies. <p></p> Objective: In this review, we describe some relevant molecular features of the cardiovascular disease in the context of personalized medicine, discussing how a multidisciplinary approach can favor its translation into daily patient management as a component of integrated care. <p></p> Conclusion: Prevention of the Cardiovascular disease still lacks efficient models for personalized medicine, but the definition of the individual Metabolomics may represent a promising approach for filling this gap. <p></p>.

Medienart:

E-Artikel

Erscheinungsjahr:

2017

Erschienen:

2017

Enthalten in:

Zur Gesamtaufnahme - volume:15

Enthalten in:

Current pharmacogenomics and personalized medicine - 15(2017), 1, Seite 60-66

Sprache:

Englisch

Beteiligte Personen:

Finelli, Rosa [VerfasserIn]
Pascale, Antonietta V. [VerfasserIn]
Marotta, Paola [VerfasserIn]
Guida, Anna [VerfasserIn]
Ciccarelli, Michele [VerfasserIn]

Links:

Volltext

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

OLC2000014933